Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Moricizine-induced proarrhythmia.

S M Seaborg1, M D Cowan

  • 1Department of Clinical Cardiac Electrophysiology, Marquette General Hospital, Michigan, USA.

Clinical Cardiology
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity.

Thorax·2002
Same author

High resolution computed tomography in asthma.

Thorax·1998
Same author

Becker muscular dystrophy with bundle branch reentry ventricular tachycardia.

Journal of cardiovascular electrophysiology·1998
Same author

Ultrasonic assessment of hemidiaphragmatic movement: an indirect method of evaluating mediastinal invasion in non-small cell lung cancer.

The British journal of radiology·1995
Same author

Comparison of ultrasound with fluoroscopy in the assessment of suspected hemidiaphragmatic movement abnormality.

Clinical radiology·1995
Same author

Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus.

Thorax·1994
Same journal

Real-World National Databases Versus Hypothesis-Driven Cohort Studies: A Reply to the Critique on the TURK-HF Registry Design.

Clinical cardiology·2026
Same journal

Comment on Wang et al.: Unaddressed Multiple Comparisons Risk Inflating Type, Error in Cardiovascular Specialty Nursing Research.

Clinical cardiology·2026
Same journal

Methodological and Statistical Confounding in Comparing Patient-Reported Outcomes Between Cardioversion and Ablation for Atrial Fibrillation.

Clinical cardiology·2026
Same journal

In-Hospital Cardiac Arrest Detection Performance Analysis and Comparison on Effective Feature Selection.

Clinical cardiology·2026
Same journal

Interpreting the Association Between Diuretic Intensity Score and Mortality: The Potential Roles of Diuretic Responsiveness and Mineralocorticoid Receptor Antagonist Therapy.

Clinical cardiology·2026
Same journal

Heart Failure With Preserved Ejection Fraction-Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA Cohort.

Clinical cardiology·2026
See all related articles

Moricizine, a Class I antiarrhythmic, may cause life-threatening proarrhythmia, contrary to previous assumptions. This cardiac arrhythmia risk highlights the need for caution, especially in patients with structural heart disease.

Area of Science:

  • Pharmacology
  • Cardiology

Background:

  • Moricizine is a Class I antiarrhythmic drug approved for life-threatening ventricular arrhythmias.
  • Previous studies suggested a low proarrhythmic potential for moricizine.
  • The drug was notably studied in the Cardiac Arrhythmia Suppression Trial.

Observation:

  • A case of life-threatening late proarrhythmia caused by moricizine is reported.
  • The authors share their clinical experience with moricizine.

Findings:

  • Moricizine demonstrates a significant proarrhythmic potential.
  • This potential can manifest as late-onset arrhythmias.

Implications:

  • Moricizine should not be used empirically for ventricular ectopy.

Related Experiment Videos

  • Caution is advised when prescribing moricizine, particularly in patients with underlying structural heart disease.
  • Clinical use of moricizine requires careful risk-benefit assessment due to its proarrhythmic effects.